Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s12672-025-04287-0 http://scihub22266oqcxt.onion/10.1007/s12672-025-04287-0 41391067!?!41391067 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=41391067&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Discov+Oncol 2025 ; ? (?): ? Nephropedia Template TP {{tp|p=41391067|t=2025. Clinicopathological characteristics and prognostic factors of invasive micropapillary carcinoma of the breast |pdf=|usr=}}{{41391067}} gab.com Text Clinicopathological characteristics and prognostic factors of invasive micropapillary carcinoma of the breast JO: Discov Oncol http://www.kidney.de/pget.php?&tw=1&pmid=41391067 #FOAvip PURPOSE: To evaluate the clinicopathological characteristics of breast invasive micropapillary carcinoma (IMPC) and identify factors associated with recurrence and metastasis. METHODS: The study retrospectively analyzed 401 cases of breast IMPC diagnosed between 2017 and 2021. The primary endpoint was recurrence and metastasis-free survival (RMFS). Secondary endpoints included locoregional recurrence-free survival (LRRFS) and distant metastasis-free survival (DMFS). Survival was estimated using the Kaplan-Meier method and compared with the log-rank test. Univariable and multivariable Cox regression analyses were performed to identify prognostic factors. Continuous variables were categorized using maximum log-rank statistics to optimize group stratification. RESULTS: The median follow-up duration was 46.9 months (range, 1-92 months). The 5-year RMFS, LRRFS and DMFS rates were 86.0% (95% CI, 82.2%-90.0%), 97.5% (95% CI, 95.8%-99.3%) and 86.5% (95% CI, 82.8%-90.5%), respectively. Multivariable Cox analysis showed that maximum tumor diameter (</= 1.7 cm vs. >1.7 cm, P = 0.018), the log odds of positive lymph nodes (LODDS) (</= 0 vs. >0, P = 0.008), histological grade (I-II vs. III, P = 0.002), and receipt of neoadjuvant chemotherapy (P = 0.003) were independent predictors of recurrence and metastasis. CONCLUSION: Breast IMPC carries a relatively high risk of recurrence and metastasis. Tumor size, LODDS, histologic grade, and neoadjuvant chemotherapy were independently associated with outcomes, underscoring the need for closer clinical monitoring and refined risk stratification in this subtype. Twit Text FOAVip Clinicopathological characteristics and prognostic factors of invasive micropapillary carcinoma of the breast ????Discov Oncol http://www.kidney.de/pget.php?&tw=1&pmid=41391067 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=41391067 #FOAvip English Wikipedia <ref>{{Cite pmid|41391067}}</ref> Clinicopathological characteristics and prognostic factors of invasive micropapillary carcinoma of the breast #MMPMID41391067 Qiu Y; Meng X; Chang X; Zhang Y; Hao F Discov Oncol 2025[Dec]; ? (?): ? PMID41391067show ga PURPOSE: To evaluate the clinicopathological characteristics of breast invasive micropapillary carcinoma (IMPC) and identify factors associated with recurrence and metastasis. METHODS: The study retrospectively analyzed 401 cases of breast IMPC diagnosed between 2017 and 2021. The primary endpoint was recurrence and metastasis-free survival (RMFS). Secondary endpoints included locoregional recurrence-free survival (LRRFS) and distant metastasis-free survival (DMFS). Survival was estimated using the Kaplan-Meier method and compared with the log-rank test. Univariable and multivariable Cox regression analyses were performed to identify prognostic factors. Continuous variables were categorized using maximum log-rank statistics to optimize group stratification. RESULTS: The median follow-up duration was 46.9 months (range, 1-92 months). The 5-year RMFS, LRRFS and DMFS rates were 86.0% (95% CI, 82.2%-90.0%), 97.5% (95% CI, 95.8%-99.3%) and 86.5% (95% CI, 82.8%-90.5%), respectively. Multivariable Cox analysis showed that maximum tumor diameter (1.7 cm, P = 0.018), the log odds of positive lymph nodes (LODDS) (0, P = 0.008), histological grade (I-II vs. III, P = 0.002), and receipt of neoadjuvant chemotherapy (P = 0.003) were independent predictors of recurrence and metastasis. CONCLUSION: Breast IMPC carries a relatively high risk of recurrence and metastasis. Tumor size, LODDS, histologic grade, and neoadjuvant chemotherapy were independently associated with outcomes, underscoring the need for closer clinical monitoring and refined risk stratification in this subtype. ?Clinicopathological characteristics and prognostic factors of invasive(epmc).pdf DeepDyve Pubget Overpricing